NCT01165892View on ClinicalTrials.gov

Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pulmonary Embolism
Interventions
DRUG

Gadofosveset Triodium

Use of 0.03 mmol/Kg of gadofosveset trisodium (Ablavar)once with intravascular half life of up to 1 hr and optimal arterial imaging out to 20-30 minutes.

Sponsors

Collaborators (1)

Lantheus Medical Imaging
All Listed Sponsors
collaborator

Lantheus Medical Imaging

INDUSTRY

lead

Washington University School of Medicine

OTHER